Home » News » October 2024

October, 2024

R&D Tax Registrations – Deadline this month

October 1st, 2024

Companies seeking to register R&D Activities conducted during the Year Ended 31 December 2023 (companies that have a December Year End for tax) who are yet to do so should note that the Registration Deadline is the end of October 2024. The extensions granted during COVID no longer apply, and the statutory deadlines revert to normal (10 months after the end of a company’s financial year). There are mechanisms available under the IR&D Act and IRD Decision making provisions that allow for […]

Read More

Recent AusIndustry explanations on registration processing timeframes

September 2nd, 2024

This time of year (shortly after financial year end) companies can often be eager to receive their R&D Registration notices to facilitate lodgement of R&D Claims within their company tax returns. This is particularly so for SME tax loss companies who may be seeking to receive Refundable R&D Tax Offsets within their tax returns. In a recent update, AusIndustry has commented on factors which impact registration processing times. The update noted: There are several factors which may impact the time it […]

Read More

ATO Guidance noting Common errors in R&D Registrations and Schedules

August 5th, 2024

When processing R&D Applications and R&D Schedules, both AusIndustry (DISR) and the ATO have processes in place to conduct integrity checks of claims and identity claims for compliance activity.   Claims found to have anomalies, or that may require more detailed compliance will likely be subject to delays in processing of R&D tax offsets.   On 17 July 2024 the ATO posted updated guidance that notes issues that may be the subject of initial registration checks and delays. These registration/integrity reviews may […]

Read More

Significant Refundable R&D Offsets receipts reported to the ASX in recent months

July 8th, 2024

Over recent months, a number of companies have reported to the ASX receipt of substantial Refundable R&D Tax Offsets. Notable receipts include: Recce Pharmaceuticals (ASX: RCE) received $2.6 M related to its anti-infective platform; Latrobe Magnesium (ASX: LMG) received $12.5 M related to Magnesium extraction technology; Group 6 Metals (ASX:G6M) received $14.3 M related to processes for producing higher value tungsten products Orthocell Limited (ASX: SNT) received $3.05 M related to its mobility regeneration technology; Botanix (ASX: BOT) received $3 […]

Read More

Categories

Archives